公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2023 | Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease | Chen, Ching-Ya; Chou, Fang-Yi; Chang, Ya-Gin; Ho, Chin-Jui; Wu, Kuo-Chen; Hsu, Chia-Lin; Chern, Yijuang; CHUN-JUNG LIN | Neurobiology of disease | 1 | ||
2021 | Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy | Chang, Ching-Pang; Chang, Ya-Gin; Chuang, Pei-Yun; Nguyen, Thi Ngoc Anh; Wu, Kuo-Chen; Chou, Fang-Yi; Cheng, Sin-Jhong; Chen, Hui-Mei; Jin, Lee-Way; Carvalho, Kevin; Huin, Vincent; Buée, Luc; Liao, Yung-Feng; CHUN-JUNG LIN ; Blum, David; Chern, Yijuang | Acta Neuropathologica Communications | 6 | 6 | |
2007 | 好公司是否為好股票?-以天下雜誌「標竿企業」進行研究 | 周芳儀; Chou, Fang-Yi | ||||
2006 | 現代行政國家與憲政思想之變遷 | 周芳怡; Chou, Fang-Yi |